Healthequity Inc (HQY) Insider Jon Kessler Sells 20,442 Shares

Healthequity Inc (NASDAQ:HQY) insider Jon Kessler sold 20,442 shares of the business’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $55.02, for a total transaction of $1,124,718.84. Following the sale, the insider now directly owns 446,332 shares of the company’s stock, valued at $24,557,186.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Jon Kessler also recently made the following trade(s):

  • On Wednesday, February 14th, Jon Kessler sold 1,332 shares of Healthequity stock. The stock was sold at an average price of $55.00, for a total transaction of $73,260.00.
  • On Thursday, January 25th, Jon Kessler sold 40,000 shares of Healthequity stock. The stock was sold at an average price of $49.47, for a total transaction of $1,978,800.00.

Healthequity Inc (NASDAQ:HQY) opened at $54.86 on Friday. The stock has a market cap of $3,330.00, a P/E ratio of 74.14, a P/E/G ratio of 2.09 and a beta of 1.70. Healthequity Inc has a 1-year low of $37.62 and a 1-year high of $55.34.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.13 by $0.04. The company had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business’s quarterly revenue was up 31.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.10 earnings per share. equities research analysts forecast that Healthequity Inc will post 0.73 earnings per share for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in HQY. UBS Asset Management Americas Inc. boosted its holdings in shares of Healthequity by 24.3% in the second quarter. UBS Asset Management Americas Inc. now owns 28,342 shares of the company’s stock valued at $1,412,000 after buying an additional 5,544 shares during the period. California Public Employees Retirement System boosted its holdings in shares of Healthequity by 2.2% in the second quarter. California Public Employees Retirement System now owns 92,200 shares of the company’s stock valued at $4,594,000 after buying an additional 2,000 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Healthequity by 25.3% in the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock valued at $23,591,000 after buying an additional 95,514 shares during the period. Shelton Capital Management acquired a new position in shares of Healthequity in the second quarter valued at approximately $217,000. Finally, State Street Corp boosted its holdings in Healthequity by 10.8% during the second quarter. State Street Corp now owns 1,172,117 shares of the company’s stock worth $58,411,000 after purchasing an additional 114,294 shares during the last quarter. Institutional investors own 98.63% of the company’s stock.

HQY has been the subject of a number of analyst reports. Robert W. Baird boosted their price objective on shares of Healthequity from $48.00 to $49.00 and gave the company a “neutral” rating in a report on Wednesday, February 7th. BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a report on Tuesday, November 7th. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $57.00 price objective for the company in a report on Saturday, February 10th. Cantor Fitzgerald boosted their price objective on shares of Healthequity from $56.00 to $60.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Finally, Citigroup initiated coverage on shares of Healthequity in a report on Thursday, January 4th. They set a “buy” rating for the company. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the stock. Healthequity presently has an average rating of “Buy” and an average price target of $56.67.

COPYRIGHT VIOLATION NOTICE: “Healthequity Inc (HQY) Insider Jon Kessler Sells 20,442 Shares” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/18/healthequity-inc-hqy-insider-jon-kessler-sells-20442-shares.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply